Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Leukopenia and PIK3CA[original query] |
---|
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma. Cancer medicine 2013 Jun 2 (3): 325-33. Werner Dominique, Atmaca Akin, Pauligk Claudia, Pustowka Anette, Jäger Elke, Al-Batran Salah-Edd |
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar . Pietanza Catherine M, Hellmann Matthew D, Fiore John J, Smith-Marrone Stephanie, Basch Ethan M, Schwartz Lawrence H, Ginsberg Michelle S, Shouery Marwan, Newman Samantha K, Shaw Mary, Rogak Lauren J, Lash Alex, Hilden Patrick, Kris Mark |
Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers. Oncotarget 2018 3 9 (19): 14909-14921. Tono Yasutaka, Ishihara Mikiya, Miyahara Yoshihiro, Tamaru Satoshi, Oda Hiroyasu, Yamashita Yoshiki, Tawara Isao, Ikeda Hiroaki, Shiku Hiroshi, Mizuno Toshiro, Katayama Naoyu |
Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 6 28 (17): 3677-3685. Yin Wenjin, Wang Yaohui, Wu Ziping, Ye Yumei, Zhou Liheng, Xu Shuguang, Lin Yanping, Du Yueyao, Yan Tingting, Yang Fan, Zhang Jie, Liu Qiang, Lu Jinso |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: